1. Medtech Insight
  2. >>Geography
  3. >>Europe

Medtech Further Examines Repercussions With EU On Cusp Of Adopting World-First AI Act

 
• By Natasha Barrow

Medtech manufacturers and notified bodies must be prepared to allocate significant resource and build their AI expertise now the EU’s AI Act is on the cusp of being adopted.

AI Act
• Source: Shutterstock

After 36 hours of negotiation, the Council of the EU and the European Parliament reached a provisional agreement on the EU’s Artificial Intelligence Act. The AI Act is now expected to enter into force in early 2024, with a transition period of two years, as long as final formalities go to plan.

The AI Act is one of the world’s first attempts to address the rapidly evolving technology of AI

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Disparities — Including Financials Shortcomings — Remain In Women’s Health, Execs Say

 
• By Brian Bossetta

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.